Phillip Hong Lam MD FACC
Heart Failure & Transplantation
Advanced Heart Failure and Transplant Cardiologist
3800 Reservoir Rd NWDept of MedicineWashington, DC 20007
Fax+1 877-303-1460
Overview of Dr. Lam
Dr. Phillip Lam is a Cardiologist based in Washington, DC, with a subspeciality in Heart Failure & Transplantation. He completed his education and fellowships at renowned institutions like the University of Vermont College of Medicine and MedStar Health/Georgetown-Washington Hospital Center. He also completed a specialized fellowship in Advanced Heart Failure and Transplant Cardiology at Brigham and Women's Hospital. Dr. Lam has expertise in managing cardiogenic shock, cardiomyopathies, sarcoidosis-related cardiomyopathy, lvad, and heart failure and transplantation. Furthermore, his contributions to research in his field are significant, having authored several publications in high-impact journals like 'The American Journal of Cardiology' and 'Circulation. Heart Failure'.
Education & Training
Mass General Brigham/Brigham and Women's HospitalFellowship, Advanced Heart Failure and Transplant Cardiology, 2018 - 2019
MedStar Health Georgetown UniversityFellowship, Cardiovascular Disease, 2015 - 2018- MedStar Health Georgetown University/Georgetown HospitalResidency, Internal Medicine, 2015
University of Vermont College of MedicineClass of 2011
Certifications & Licensure
DC State Medical License 2011 - 2026
MD State Medical License 2022 - 2026
VA State Medical License 2013 - 2026
MA State Medical License 2018 - 2019
American Board of Internal Medicine Internal Medicine- American Board of Internal Medicine Advanced Heart Failure and Transplant Cardiology
- American Board of Internal Medicine Cardiovascular Disease
Publications & Presentations
PubMed
- Lower Risk of Death and Kidney Failure Associated with Higher Target (vs Below-Target) Doses of RAS Inhibitors in Octogenarians with HFrEF.Mo-Kyung Sin, Richard M Allman, Charles Faselis, Wilbert S Aronow, Cynthia J Brown
The American Journal of Medicine. 2025-04-01 - Digoxin Discontinuation in Patients With HFrEF on Beta-Blockers: Implication for Future 'Knock-Out Trials' in Heart Failure.Phillip H Lam, Kevin Liu, Amiya A Ahmed, Javed Butler, Paul A Heidenreich
The American Journal of Medicine. 2025-03-01 - 1 citationsOutcomes of KDIGO-Defined CKD in U.S. Veterans With HFpEF, HFmrEF, and HFrEF.Samir Patel, Venkatesh K Raman, Charles Faselis, Gregg C Fonarow, Phillip H Lam
JACC. Heart Failure. 2025-03-01
Professional Memberships
- Member
- Member
- Heart Failure Society of America - HFSAMember
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
